Monport Integrated Metal Color Fiber Laser Brings a Little Shock to the Laser Engraving Industry
Aug 27, 2023If You Want More Than One Thing From This List, Congratulations: You May Be A Responsible Adult
Aug 17, 2023Laser Additive Solutions invests in Trumpf TruPrint 3000 as it targets UK space sector
Aug 31, 2023Machine learning models for efficient characterization of Schottky barrier photodiode internal parameters
Aug 30, 2023Global Laser Cleaning Machine Market Size and Forecast
Aug 20, 2023Elogio Asia banks on science to promote long
Country Business Reports interviews and articles by Discovery Reports
For premier therapeutic medical aesthetics concept provider Elogio Asia, beauty is a science. Beyond addressing immediate aesthetic concerns, Elogio Asia’s scientific and evidence-based approach empowers patients to make informed decisions that pave the way for long-term skin health.
“Elogio Asia’s impact on medical aesthetics is defined by our focus on patient skin health and an emphasis on education. Our unique contribution lies in blending advanced therapeutic aesthetics devices with comprehensive education for our growth partners and their patients,” said Elogio Asia founder Khim Chew.
Elogio Asia continuously improves its product line-up to address emerging skin health needs. Its current portfolio includes Sylfirm X, the first FDA-approved pulsed and continuous wave 300-micron skin-targeted RF microneedling system; LDM Triple, a local dynamic microscopic cell cleanser with a distinctive 19MHz triple-ultrasound wave technology; QuadroStarPro Yellow, a unique laser treating superficial vessels and pigmented lesions; and the Neo Elite by Aerolase, a 650-microsecond, ultra comfortable and high-efficacy skin health laser addressing common skin lesions inclusive of melasma and acne.
For Elogio Asia, keeping its pulse on market trends and maintaining strong relationships with top industry professionals worldwide help identify market gaps. One such gap is the need for skin health targeted injectable treatments. To address this, Elogio Asia is currently developing a new skin health injectable product line. Aiming to become a leader in the Asia-Pacific medical aesthetics market, Elogio Asia has established offices in Singapore, Malaysia, Indonesia, the Philippines, Thailand, Vietnam, Myanmar and Australia.
To mark its 20th anniversary this year, Elogio Asia is holding the inaugural opening of its education platform, Elogio Educates APAC, in the fourth quarter of 2023. Headquartered in Kuala Lumpur, Malaysia, Elogio Educates APAC will be the driving force and the fulfilment of the company’s passion in aesthetic medicine. It will offer new learning opportunities about the most up-to-date industry developments and sharpen the precision skill set of aesthetic doctors.
“We plan to empower our growth partners, practitioners and patients with the knowledge leading to improved treatment outcomes. We look forward to the future with the launch of the academy, marking a new era of growth for Elogio Asia and the industry,” Chew said.
Country Business Reports interviews and articles by Discovery ReportsDiscoveryreports.com